Clovis Oncology, Inc. CLVS
Day range unavailable
52-week range unavailable
- Open
- —
- Prev close
- 0.00
- Mkt cap
- 11.77M
- Vol
- 0
- Avg vol
- 0
- EPS
- 0.00
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- —
- High
- —
- Forward P/E
- -0.10
- Beta
- 0.22
- Short ratio
- 4.63
- Inst. own
- 25.90%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Nov 9, 2022
- 50-d avg
- 0.517402
- 200-d avg
- 1.26
- 1y target
- 2.00
5Y chart
Chart tools
Chart is warming up
The five-year price history for CLVS has not been loaded yet. Try again in a moment.
P/E -1.2×
P/S 2.2×
P/B -1.2×
P/FCF -1.7×
EV/EBITDA -7.2×
EV/Sales 5.5×
FCF Yield -59.8%
Gross Margin 73.9%
Operating Margin -156.8%
Net Margin -177.8%
ROE 94.9%
ROIC -66.3%
ROA -55.9%
Revenue -9.6%
Operating Income 22.8%
EPS (diluted) 50.2%
Free Cash Flow 24.8%
Current Ratio 1.6×
Quick Ratio 1.5×
Debt / Equity -2.3×
Net Debt / EBITDA -4.3×
Interest Coverage -7.4×
Dividend Yield 0.0%
Payout Ratio 0.0%
Annual · latest fiscal year ends 2021-12-31